JP2022507828A5 - - Google Patents
Info
- Publication number
- JP2022507828A5 JP2022507828A5 JP2021527948A JP2021527948A JP2022507828A5 JP 2022507828 A5 JP2022507828 A5 JP 2022507828A5 JP 2021527948 A JP2021527948 A JP 2021527948A JP 2021527948 A JP2021527948 A JP 2021527948A JP 2022507828 A5 JP2022507828 A5 JP 2022507828A5
- Authority
- JP
- Japan
- Prior art keywords
- cre0058
- cre0065
- cre0051
- cre0066
- crm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024075266A JP7860164B2 (ja) | 2018-11-19 | 2024-05-07 | 肝臓特異的調節性核酸配列 |
| JP2026075526A JP2026124829A (ja) | 2018-11-19 | 2026-04-28 | 肝臓特異的調節性核酸配列 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1818816.9A GB201818816D0 (en) | 2018-11-19 | 2018-11-19 | Regulatory nucleic acid sequences |
| GB1818816.9 | 2018-11-19 | ||
| PCT/GB2019/053267 WO2020104782A1 (en) | 2018-11-19 | 2019-11-19 | Liver-Specific Regulatory Nucleic Acid Sequences |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075266A Division JP7860164B2 (ja) | 2018-11-19 | 2024-05-07 | 肝臓特異的調節性核酸配列 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022507828A JP2022507828A (ja) | 2022-01-18 |
| JP2022507828A5 true JP2022507828A5 (enExample) | 2022-11-25 |
| JP7489161B2 JP7489161B2 (ja) | 2024-05-23 |
Family
ID=64740036
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021527948A Active JP7489161B2 (ja) | 2018-11-19 | 2019-11-19 | 肝臓特異的調節性核酸配列 |
| JP2024075266A Active JP7860164B2 (ja) | 2018-11-19 | 2024-05-07 | 肝臓特異的調節性核酸配列 |
| JP2026075526A Pending JP2026124829A (ja) | 2018-11-19 | 2026-04-28 | 肝臓特異的調節性核酸配列 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075266A Active JP7860164B2 (ja) | 2018-11-19 | 2024-05-07 | 肝臓特異的調節性核酸配列 |
| JP2026075526A Pending JP2026124829A (ja) | 2018-11-19 | 2026-04-28 | 肝臓特異的調節性核酸配列 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12590129B2 (enExample) |
| EP (2) | EP3883951A1 (enExample) |
| JP (3) | JP7489161B2 (enExample) |
| CN (1) | CN113454104A (enExample) |
| AU (2) | AU2019382955B2 (enExample) |
| CA (1) | CA3120253A1 (enExample) |
| GB (1) | GB201818816D0 (enExample) |
| IL (1) | IL283219A (enExample) |
| WO (2) | WO2020104783A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021207526A1 (en) | 2020-04-09 | 2021-10-14 | The Regents Of The University Of California | Humanized notch receptors with hinge domain |
| KR102726511B1 (ko) | 2021-01-20 | 2024-11-07 | 주식회사 큐로젠 | Ssu72 단백질 또는 Ssu72 단백질을 코딩하는 뉴클레오티드를 포함하는 간암 예방 또는 치료용 약학적 조성물 |
| AU2022214501B2 (en) | 2021-01-29 | 2025-05-22 | Curogen Technology Co., Ltd. | Pharmaceutical composition for treating liver diseases using ssu72 |
| WO2023008925A1 (ko) * | 2021-07-29 | 2023-02-02 | 주식회사 리보퓨틱스 | 융합 프로모터, 이를 포함하는 재조합 벡터 및 이를 이용하는 간암 치료용 조성물 |
| JP2026516710A (ja) * | 2023-04-20 | 2026-05-26 | アスクバイオ インコーポレイテッド | 肝臓特異的調節核酸配列 |
| CN116555266B (zh) * | 2023-06-09 | 2024-11-12 | 呈诺再生医学科技(北京)有限公司 | 肝脏特异性表达的重组启动子和载体及其在肝脏相关疾病治疗中的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5721096A (en) * | 1991-01-24 | 1998-02-24 | Children's Medical Center Corporation | Methods of screening for compounds with ability to alter apolipoprotein AI gene expression |
| US5578444A (en) | 1991-06-27 | 1996-11-26 | Genelabs Technologies, Inc. | Sequence-directed DNA-binding molecules compositions and methods |
| US6268212B1 (en) | 1993-10-18 | 2001-07-31 | Amgen Inc. | Tissue specific transgene expression |
| EP0933997A4 (en) | 1996-09-06 | 2000-08-16 | Chiron Corp | METHODS AND COMPOSITIONS FOR LIVER-SPECIFIC ADMINISTRATION OF THERAPEUTIC MOLECULES USING RECOMBINANT AAV VECTORS |
| US7351813B2 (en) | 2000-06-20 | 2008-04-01 | The Board Of Trustees Of The Leland Stanford Junior University | Liver-specific gene expression cassettes, and methods of use |
| WO2002092134A1 (en) | 2001-05-14 | 2002-11-21 | Cell Genesys, Inc. | Lentiviral vectors encoding clotting factors for gene therapy |
| CN102634515B (zh) | 2008-02-14 | 2013-11-06 | 财团法人牧岩生命工学研究所 | 适于表达用于基因治疗的编码序列的表达载体 |
| CN102628041B (zh) | 2008-02-14 | 2013-09-11 | 财团法人牧岩生命工学研究所 | 适于表达用于基因治疗的编码序列的表达载体 |
| US9617548B2 (en) | 2008-04-22 | 2017-04-11 | Vib Vzw | Liver-specific nucleic acid regulatory elements and methods and use thereof |
| US8815779B2 (en) | 2009-09-16 | 2014-08-26 | SwitchGear Genomics, Inc. | Transcription biomarkers of biological responses and methods |
| EP2479278A1 (en) | 2011-01-25 | 2012-07-25 | Synpromics Ltd. | Method for the construction of specific promoters |
| JP6879486B2 (ja) * | 2015-03-17 | 2021-06-02 | フリーイェ・ユニヴェルシテイト・ブリュッセルＶｒｉｊｅ Ｕｎｉｖｅｒｓｉｅｉｔ Ｂｒｕｓｓｅｌ | Ｆｖｉｉｉおよびｆｉｘ用の最適化された肝臓特異的発現系 |
| PE20181922A1 (es) | 2016-04-15 | 2018-12-11 | Univ Pennsylvania | Terapia genica para tratar la hemofilia a |
| WO2018144709A2 (en) | 2017-02-01 | 2018-08-09 | The Trustees Of The University Of Pennsylvania | Gene therapy for treating citrullenemia |
| BR112019024608A2 (pt) | 2017-05-24 | 2020-06-23 | Universitat Autonoma De Barcelona | Construto de expressão viral que compreende uma sequência de codificação do fator de crescimento de fibroblastos 21 (fgf21) |
| JP2020533971A (ja) | 2017-08-28 | 2020-11-26 | アルター・バイオサイエンス・コーポレーション | Ｉｌ−１５をベースとするｉｌ−７及びｉｌ−２１への融合物 |
| CN108588097B (zh) | 2018-04-28 | 2021-07-13 | 北京锦篮基因科技有限公司 | 改造后的hbv基因组和相关组合物及其应用 |
-
2018
- 2018-11-19 GB GBGB1818816.9A patent/GB201818816D0/en not_active Ceased
-
2019
- 2019-11-19 WO PCT/GB2019/053268 patent/WO2020104783A1/en not_active Ceased
- 2019-11-19 AU AU2019382955A patent/AU2019382955B2/en active Active
- 2019-11-19 WO PCT/GB2019/053267 patent/WO2020104782A1/en not_active Ceased
- 2019-11-19 CN CN201980089303.6A patent/CN113454104A/zh active Pending
- 2019-11-19 EP EP19809587.9A patent/EP3883951A1/en active Pending
- 2019-11-19 EP EP19809588.7A patent/EP3883952A1/en active Pending
- 2019-11-19 JP JP2021527948A patent/JP7489161B2/ja active Active
- 2019-11-19 CA CA3120253A patent/CA3120253A1/en active Pending
- 2019-11-19 US US17/295,208 patent/US12590129B2/en active Active
- 2019-11-19 US US17/295,210 patent/US12630595B2/en active Active
-
2021
- 2021-05-16 IL IL283219A patent/IL283219A/en unknown
-
2024
- 2024-05-07 JP JP2024075266A patent/JP7860164B2/ja active Active
-
2025
- 2025-12-24 AU AU2025287323A patent/AU2025287323A1/en active Pending
-
2026
- 2026-04-28 JP JP2026075526A patent/JP2026124829A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bridgen et al. | Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs | |
| Carelli et al. | Mitochondria: biogenesis and mitophagy balance in segregation and clonal expansion of mitochondrial DNA mutations | |
| Casas-Mollano et al. | CRISPR-Cas activators for engineering gene expression in higher eukaryotes | |
| Wagner | Gene duplications, robustness and evolutionary innovations | |
| JP2021526858A5 (enExample) | ||
| Yang et al. | The evo‐devo of molluscs: insights from a genomic perspective | |
| Kim et al. | Effects of NV gene knock-out recombinant viral hemorrhagic septicemia virus (VHSV) on Mx gene expression in Epithelioma papulosum cyprini (EPC) cells and olive flounder (Paralichthys olivaceus) | |
| JP2023509118A5 (enExample) | ||
| AR041752A1 (es) | Promotores sinteticos que inducen una actividad transcripcional aumentada en celulas cardiacas | |
| JP2021522858A5 (enExample) | ||
| JP2006526394A5 (enExample) | ||
| JP2022535412A5 (enExample) | ||
| JP2019528793A5 (enExample) | ||
| Katano et al. | Cardiac septation in heart development and evolution | |
| JPS6156200A (ja) | 修飾インタ−フエロン | |
| Grisorio et al. | Gene therapy for cardiac diseases: methods, challenges, and future directions | |
| Zhang et al. | The activation of antiviral RNA interference not only exists in neural progenitor cells but also in somatic cells in mammals | |
| JP2023118937A5 (enExample) | ||
| JP2024513907A5 (enExample) | ||
| Weasner et al. | Retinal expression of the Drosophila eyes absent gene is controlled by several cooperatively acting cis-regulatory elements | |
| JP2022533813A5 (enExample) | ||
| Jane et al. | Understanding fetal globin gene expression: a step towards effective HbF reactivation in haemoglobinopathies. | |
| Jeffery | Evolution of ascidian development | |
| Niculescu | Cancer exploits a late premetazoan gene module conserved in the human genome | |
| CN107287216B (zh) | CvBV5-3基因在降低果蝇免疫力和制备免疫低下型果蝇模型中的应用 |